FOXA2 and Parkinson disease: Studies have shown that in a rat model of Parkinson’s disease, co-transplantation of neural stem/progenitor cells (NSCs/NPCs) with midbrain-derived astrocytes overexpressing the transcription factors NURR1 and FOXA2 promotes graft maturation and survival, thereby improving treatment outcomes (Tsai, 2018).